Eddit

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 7: Zeile 7:
  
 
*'''[[Reviews on covid19 disease]]'''
 
*'''[[Reviews on covid19 disease]]'''
 +
{{tp|p=32363726|t=2020. The Novel Coronavirus - Latest Findings |pdf=|usr=}}
 +
{{tp|p=32144890|t=2020. The Novel Coronavirus ? A Snapshot of Current Knowledge |pdf=|usr=}}
 +
{{tp|p=32032682|t=ä. Pathogenicity and transmissibility of 2019-nCoV?A quick overview and comparison with other emerging viruses |pdf=|usr=}}
 +
{{tp|p=32017984|t=2020. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China |pdf=|usr=}}
 +
{{tp|p=32226946|t=ä. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don?t |pdf=|usr=}}
 +
{{tp|p=32169119|t=2020. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak ? an update on the status |pdf=|usr=}}
 +
{{tp|p=32297723|t=2020. COVID-2019: update on epidemiology, disease spread and management |pdf=|usr=}}
 +
  
 
*'''[[Clinical guidelines and advice]]'''
 
*'''[[Clinical guidelines and advice]]'''
 +
{{tp|p=C7155395|t=ä. German recommendations for critically ill patients with COVID?19 |pdf=|usr=}}
 +
{{tp|p=32166350|t=ä. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 |pdf=|usr=}}
 +
{{tp|p=32029004|t=2020. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) |pdf=|usr=}}
 +
{{ttp|p=32307014|t=2020. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19 |pdf=|usr=}}
 +
  
 
----
 
----
Zeile 17: Zeile 30:
 
{{tp|p=32007145|t=2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding |pdf=|usr=}}
 
{{tp|p=32007145|t=2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding |pdf=|usr=}}
 
{{tp|p=32342926|t=2020. Properties of Coronavirus and SARS-CoV-2 |pdf=|usr=}}
 
{{tp|p=32342926|t=2020. Properties of Coronavirus and SARS-CoV-2 |pdf=|usr=}}
 
+
{{tp|p=32194253|t=ä. Molecular basis of COVID-19 relationships in different species: a one health perspective |pdf=|usr=}}
 +
{{tp|p=32302675|t=ä. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses |pdf=|usr=}}
 +
{{tp|p=32165386|t=2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal |pdf=|usr=}}
 +
{{ttp|p=32289821|t=ä. Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense |pdf=|usr=}}
  
  
 
*'''[[Target binding and uptake]]'''
 
*'''[[Target binding and uptake]]'''
 +
{{tp|p=32199943|t=ä. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |pdf=|usr=}}
 +
{{ttp|p=32362314|t=ä. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells |pdf=|usr=}}
 +
 
*'''[[Cytopathic effects]]'''
 
*'''[[Cytopathic effects]]'''
  
Zeile 32: Zeile 51:
  
 
*'''[[Immunology]]'''
 
*'''[[Immunology]]'''
 +
{{tp|p=32259560|t=ä. Interleukin-6 as a potential biomarker of COVID-19 progression |pdf=|usr=}}
 +
{{ttp|p=32092539|t=2020. Is COVID-19 receiving ADE from other coronaviruses?|pdf=|usr=}}
 +
{{tp|p=32268188|t=ä. It is too soon to attribute ADE to COVID-19 |pdf=|usr=}}
 +
{{tp|p=32361001|t=ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes |pdf=|usr=}}
 +
{{ttp|p=32305501|t=ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |pdf=|usr=}}
 +
{{tp|p=32248387|t=ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution |pdf=|usr=}}
 +
  
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
 
{{tp|p=32353251|t=ä. COVID-19 cytokine storm: the interplay between inflammation and coagulation |pdf=|usr=}}
 
{{tp|p=32353251|t=ä. COVID-19 cytokine storm: the interplay between inflammation and coagulation |pdf=|usr=}}
 +
{{tp|p=32339596|t=ä. Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response |pdf=|usr=}}
 +
 +
 
----
 
----
  
Zeile 65: Zeile 94:
 
{{tp|p=32360126|t=2020. Myocardial injury and COVID-19: Possible mechanisms |pdf=|usr=}}
 
{{tp|p=32360126|t=2020. Myocardial injury and COVID-19: Possible mechanisms |pdf=|usr=}}
  
 +
{{tp|p=32319272|t=2020. COVID-19 and cardiovascular disorder |pdf=|usr=}}
 +
{{tp|p=32340429|t=2020. The role of natriuretic peptide estimation in severe COVID-19 |pdf=|usr=}}
  
  
 
*'''[[Neurology, ophthalmology, orl]]'''
 
*'''[[Neurology, ophthalmology, orl]]'''
 
+
{{tp|p=32305563|t=ä. Features of anosmia in COVID-19 |pdf=|usr=}}
  
 
*'''[[Dermatology]]'''
 
*'''[[Dermatology]]'''
Zeile 76: Zeile 107:
 
{{tp|p=32336473|t=ä. COVID-19 y aparato digestivo |pdf=|usr=}}
 
{{tp|p=32336473|t=ä. COVID-19 y aparato digestivo |pdf=|usr=}}
 
{{tp|p=32240876|t=2020. Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms |pdf=|usr=}}
 
{{tp|p=32240876|t=2020. Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms |pdf=|usr=}}
 
+
{{tp|p=32342369|t=2020. Wie das Coronavirus den Magen-Darm-Trakt angreift: Seminar / Gastromodul |pdf=|usr=}}
  
 
*'''[[Kidney, urology]]'''
 
*'''[[Kidney, urology]]'''
Zeile 83: Zeile 114:
  
 
*'''[[Pathobiology]]'''
 
*'''[[Pathobiology]]'''
 
+
{{tp|p=32243911|t=ä. C-reactive protein levels in the early stage of COVID-19 |pdf=|usr=}}
 
+
{{tp|p=32291399|t=ä. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies |pdf=|usr=}}
  
 
*'''[[Disease Models]]'''
 
*'''[[Disease Models]]'''
Zeile 90: Zeile 121:
 
*'''[[Similar diseases and pathomechanisms]]'''
 
*'''[[Similar diseases and pathomechanisms]]'''
 
{{tp|p=32370951|t=ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic |pdf=|usr=}}
 
{{tp|p=32370951|t=ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic |pdf=|usr=}}
 +
{{tp|p=32341622|t=2020. SARS-CoV-2: Camazotz s Curse |pdf=|usr=}}
 +
{{tp|p=32246819|t=2020. Pulmonary High-Resolution Computed Tomography (HRCT) Findings of Patients with Early-Stage Coronavirus Disease 2019 (COVID-19) in Hangzhou, China |pdf=|usr=}}
 +
 +
 +
  
 
----
 
----
Zeile 95: Zeile 131:
  
 
*'''[[Diagnosis (Laboratory)]]'''
 
*'''[[Diagnosis (Laboratory)]]'''
 +
{{tp|p=32333644|t=2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 |pdf=|usr=}}
 +
{{tp|p=32183357|t=2020. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics |pdf=|usr=}}
 +
{{tp|p=32106462|t=2020. Disposable DNA Amplification Chips with Integrated Low-Cost Heaters ? |pdf=|usr=}}
 +
 +
  
  
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 +
{{tp|p=32367213|t=ä. CT-Verlauf einer Coronavirus(2019-nCoV)-Pneumonie |pdf=|usr=}}
 +
{{tp|p=32358406|t=2020. COVID-19 with cystic features on computed tomography: A case report |pdf=|usr=}}
 +
  
  
Zeile 105: Zeile 149:
  
 
*'''[[Respiration mgmt]]'''
 
*'''[[Respiration mgmt]]'''
 +
{{tp|p=32336080|t=2020. Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience |pdf=|usr=}}
 +
{{tp|p=32236089|t=2020. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR) |pdf=|usr=}}
 +
{{tp|p=32268719|t=2020. Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?|pdf=|usr=}}
 +
 +
  
 
*'''[[Risk and special populations]]'''
 
*'''[[Risk and special populations]]'''
 +
{{tp|p=32333196|t=2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak |pdf=|usr=}}
 +
{{tp|p=32271125|t=2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management |pdf=|usr=}}
 +
{{tp|p=32220612|t=2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China |pdf=|usr=}}
 +
{{tp|p=32220611|t=2020. Commentary: COVID-19 in patients with diabetes |pdf=|usr=}}
 +
{{tp|p=32275971|t=ä. COVID-19 in patients with diabetes: risk factors that increase morbidity |pdf=|usr=}}
 +
{{tp|p=32360211|t=ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease |pdf=|usr=}}
 +
{{tp|p=32360397|t=ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy |pdf=|usr=}}
 +
{{tp|p=32353356|t=ä. Obesity: the ?Achilles heel? for COVID-19?|pdf=|usr=}}
 +
{{tp|p=32333939|t=2020. Importance of metabolic health in the era of COVID-19 |pdf=|usr=}}
 +
{{tp|p=32333938|t=2020. Obesity hypoventilation syndrome and severe COVID-19 |pdf=|usr=}}
 +
{{tp|p=32320741|t=2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease |pdf=|usr=}}
 +
{{tp|p=32320740|t=ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019 |pdf=|usr=}}
 +
{{tp|p=32320742|t=ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated  now, and what should happen next? |pdf=|usr=}}
 +
{{tp|p=32271728|t=2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020 |pdf=|usr=}}
 +
{{tp|p=32345328|t=2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection |pdf=|usr=}}
 +
 +
  
 
*'''[[The morbid survivor]]'''
 
*'''[[The morbid survivor]]'''
Zeile 119: Zeile 185:
 
{{tp|p=32224310|t=ä. Clinical and virological data of the first cases of COVID-19 in Europe: a case series |pdf=|usr=}}
 
{{tp|p=32224310|t=ä. Clinical and virological data of the first cases of COVID-19 in Europe: a case series |pdf=|usr=}}
 
{{tp|p=32164830|t=2020. COVID-19 with spontaneous pneumomediastinum |pdf=|usr=}}
 
{{tp|p=32164830|t=2020. COVID-19 with spontaneous pneumomediastinum |pdf=|usr=}}
 
+
{{tp|p=32229159|t=ä. SARS-CoV-2 infection presenting with hematochezia |pdf=|usr=}}
  
  
Zeile 126: Zeile 192:
 
{{tp|p=32087116|t=2020. Asymptomatic cases in a family cluster with SARS-CoV-2 infection |pdf=|usr=}}
 
{{tp|p=32087116|t=2020. Asymptomatic cases in a family cluster with SARS-CoV-2 infection |pdf=|usr=}}
 
{{tp|p=32105632|t=ä. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study |pdf=|usr=}}
 
{{tp|p=32105632|t=ä. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study |pdf=|usr=}}
 
+
{{tp|p=32379729|t=2020. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020 |pdf=|usr=}}
 
+
{{tp|p=32214079|t=2020. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United  States, February 12-March 16, 2020 |pdf=|usr=}}
 
+
{{tp|p=32290644|t=2020. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India |pdf=|usr=}}
  
 
*'''[[Registries]]'''
 
*'''[[Registries]]'''
Zeile 142: Zeile 208:
  
 
*'''[[Candidate Compounds Covid19]]'''
 
*'''[[Candidate Compounds Covid19]]'''
 +
{{tp|p=C7158785|t=ä. Convalescent plasma: A possible treatment of COVID-19 in India |pdf=|usr=}}
 +
{{tp|p=32217166|t=2020. Chloroquine and COVID-19, where do we stand?? |pdf=|usr=}}
 +
{{tp|p=32240719|t=ä. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection |pdf=|usr=}}
 +
{{tp|p=32353355|t=ä. Testosterone, a key hormone in the context of COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32344177|t=2020. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect |pdf=|usr=}}
 +
{{tp|p=32305500|t=ä. Chloroquine paradox may cause more damage than help fight COVID-19 |pdf=|usr=}}
 +
{{tp|p=32370766|t=2020. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines |pdf=|usr=}}
 +
{{tp|p=32307014|t=2020. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19 |pdf=|usr=}}
 +
{{tp|p=32255312|t=2020. A possible probiotic (S  salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SARS-CoV-2 |pdf=|usr=}}
 +
{{tp|p=32365556|t=2020. Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-gamma as Candidates for Cytokine Storm Modulation in COVID-19 Disease |pdf=|usr=}}
 +
{{tp|p=32316270|t=2020. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help |pdf=|usr=}}
 +
{{tp|p=32231349|t=2020. Chloroquine in COVID-19: the evidence |pdf=|usr=}}
 +
{{tp|p=32231348|t=2020. Emerging prophylaxis strategies against COVID-19 |pdf=|usr=}}
 +
  
  
Zeile 172: Zeile 252:
  
 
*'''[[Running your hospital]]'''
 
*'''[[Running your hospital]]'''
 +
{{tp|p=32322988|t=ä. Umgang mit COVID-19 in der Notaufnahme: Erfahrungsbericht der interdisziplinären  Notaufnahme des Universitätsklinikums Münster |pdf=|usr=}}
 +
{{tp|p=32329322|t=2020. In considerations of robotic colorectal surgery within a COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32327626|t=2020. Management of inflammatory bowel disease during COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32225135|t=2020. Pathways for urology patients during the COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32202401|t=2020. Urology practice during COVID-19 pandemic |pdf=|usr=}}
 +
{{tp|p=32253371|t=2020. Impact of the COVID-19 pandemic on urology residency training in Italy |pdf=|usr=}}
 +
{{tp|p=32368875|t=2020. Guide for Nuclear Medicine Applications During the COVID-19 Outbreak |pdf=|usr=}}
 +
{{tp|p=32210421|t=2020. COVID-19 in intensive care  Some necessary steps for health care workers |pdf=|usr=}}
 +
{{tp|p=32297490|t=2020. COVID-19 pandemic: what consequences for cardiac rehabilitation?|pdf=|usr=}}
 
----
 
----
  
Zeile 178: Zeile 267:
 
{{tp|p=32035030|t=2020. The mental health of medical workers in Wuhan, China dealing with the 2019 novel  coronavirus |pdf=|usr=}}
 
{{tp|p=32035030|t=2020. The mental health of medical workers in Wuhan, China dealing with the 2019 novel  coronavirus |pdf=|usr=}}
 
{{tp|p=32085839|t=2020. Mental health care for medical staff in China during the COVID-19 outbreak |pdf=|usr=}}
 
{{tp|p=32085839|t=2020. Mental health care for medical staff in China during the COVID-19 outbreak |pdf=|usr=}}
 
+
{{tp|p=32291383|t=2020. Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID-19) in Hubei, China |pdf=|usr=}}
  
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 
+
{{tp|p=32294078|t=2020. Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020 |pdf=|usr=}}
  
  
Zeile 191: Zeile 280:
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 
{{tp|p=32305069|t=ä. Protecting workers aged 60?69 years from COVID-19 |pdf=|usr=}}
 
{{tp|p=32305069|t=ä. Protecting workers aged 60?69 years from COVID-19 |pdf=|usr=}}
 +
{{tp|p=32219471|t=ä. Mutterschutz ? auch im Zeitalter der Coronakrise |pdf=|usr=}}
 +
  
  
Zeile 203: Zeile 294:
  
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 +
{{tp|p=32236594|t=2020. Possibility of transmission through dogs being a contributing factor to the extreme Covid-19 outbreak in North Italy |pdf=|usr=}}
 +
  
 
*'''[[Origin of Covid19]]'''
 
*'''[[Origin of Covid19]]'''
 
*'''[[Epidemiology]]'''
 
*'''[[Epidemiology]]'''
 +
{{tp|p=32282789|t=2020. Public Health Interventions to Mitigate Early Spread of SARS-CoV-2 in Poland |pdf=|usr=}}
 +
{{tp|p=32244041|t=2020. Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19)  outside the body and in body fluids |pdf=|usr=}}
 +
{{tp|p=32088333|t=2020. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases |pdf=|usr=}}
 +
{{tp|p=32087334|t=2020. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future |pdf=|usr=}}
 +
{{tp|p=32278074|t=ä. Emergency response to the outbreak of COVID-19: the Korean case |pdf=|usr=}}
 +
{{tp|p=32379733|t=2020. Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24-April 21, 2020 |pdf=|usr=}}
 +
{{tp|p=32379731|t=2020. COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020 |pdf=|usr=}}
 +
{{tp|p=32352957|t=2020. Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U S  Cities, March 27-April 15, 2020 |pdf=|usr=}}
 +
{{tp|p=32134909|t=2020. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020 |pdf=|usr=}}
 +
{{tp|p=32324720|t=2020. Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 ? National Poison Data System, United States, January 1, 2020?March 31,  2020 |pdf=|usr=}}
 +
{{tp|p=32298247|t=2020. Characteristics of Health Care Personnel with COVID-19 - United States, February  12-April 9, 2020 |pdf=|usr=}}
 +
 +
 +
 +
 
*'''[[Failure of executive measures]]'''
 
*'''[[Failure of executive measures]]'''
 
----
 
----
Zeile 217: Zeile 325:
 
*'''[[Lost people]]'''
 
*'''[[Lost people]]'''
  
 
+
{{tp|p=32334040|t=ä. The fate of house cats during the COVID-19 pandemic |pdf=|usr=}}
 
*'''[[Lost civilization]]'''
 
*'''[[Lost civilization]]'''
 
----
 
----
Zeile 229: Zeile 337:
 
{{tp|p=32192583|t=2020. COVID-19: delay, mitigate, and communicate |pdf=|usr=}}
 
{{tp|p=32192583|t=2020. COVID-19: delay, mitigate, and communicate |pdf=|usr=}}
 
{{tp|p=32344311|t=2020. 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruc?al?ty of Fur?n and relevance w?th cancer |pdf=|usr=}}
 
{{tp|p=32344311|t=2020. 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruc?al?ty of Fur?n and relevance w?th cancer |pdf=|usr=}}
 +
{{tp|p=32360951|t=2020. The first Ramadan during COVID-19 pandemic: 1 8 billion Muslims should fast or not?|pdf=|usr=}}
 +
{{tp|p=32368884|t=2020. Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain |pdf=|usr=}}
 +
  
 
*'''[[Research tools]]'''
 
*'''[[Research tools]]'''
 
{{tp|p=C7118609|t=ä. NetNCSP: Nonoverlapping closed sequential pattern mining |pdf=|usr=}}
 
{{tp|p=C7118609|t=ä. NetNCSP: Nonoverlapping closed sequential pattern mining |pdf=|usr=}}
 +
{{tp|p=32365567|t=2020. Lab-on-a-Chip Technologies for the Single Cell Level: Separation, Analysis, and Diagnostics |pdf=|usr=}}
 +
  
  

Version vom 28. Mai 2020, 18:48 Uhr


32311318 ä. SARS-CoV-2 and viral sepsis: observations and hypotheses
32325026 2020. Endothelial cell infection and endotheliitis in COVID-19


32363726 2020. The Novel Coronavirus - Latest Findings
32144890 2020. The Novel Coronavirus ? A Snapshot of Current Knowledge
32032682 ä. Pathogenicity and transmissibility of 2019-nCoV?A quick overview and comparison with other emerging viruses
32017984 2020. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
32226946 ä. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don?t
32169119 2020. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak ? an update on the status
32297723 2020. COVID-2019: update on epidemiology, disease spread and management



C7155395 ä. German recommendations for critically ill patients with COVID?19
32166350 ä. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19
32029004 2020. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

32307014 2020. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19





32350227 2020. Characteristics of SARS-CoV-2 isolated from asymptomatic carrier in Tokyo
32007145 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
32342926 2020. Properties of Coronavirus and SARS-CoV-2
32194253 ä. Molecular basis of COVID-19 relationships in different species: a one health perspective
32302675 ä. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses
32165386 2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal

32289821 ä. Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense



32199943 ä. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2

32362314 ä. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells


32304647 2020. SARS-CoV-2 shedding and infectivity
32304646 ä. SARS-CoV-2 shedding and infectivity ? Authors reply



32259560 ä. Interleukin-6 as a potential biomarker of COVID-19 progression

32092539 2020. Is COVID-19 receiving ADE from other coronaviruses?


32268188 ä. It is too soon to attribute ADE to COVID-19
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes

32305501 ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement


32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution



32353251 ä. COVID-19 cytokine storm: the interplay between inflammation and coagulation
32339596 ä. Predictive factors of poor outcomes in the COVID-19 epidemic: Consider the inflammatory response






32307254 ä. Invasive fungal diseases during COVID-19: We should be prepared
32297939 ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise
32293646 ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens



32330428 ä. Hospital-based use of thromboprophylaxis in patients with COVID-19



32334650 ä. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
32360126 2020. Myocardial injury and COVID-19: Possible mechanisms


32319272 2020. COVID-19 and cardiovascular disorder
32340429 2020. The role of natriuretic peptide estimation in severe COVID-19



32305563 ä. Features of anosmia in COVID-19



32336473 ä. COVID-19 y aparato digestivo
32240876 2020. Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
32342369 2020. Wie das Coronavirus den Magen-Darm-Trakt angreift: Seminar / Gastromodul




32243911 ä. C-reactive protein levels in the early stage of COVID-19
32291399 ä. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies


32370951 ä. Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic
32341622 2020. SARS-CoV-2: Camazotz s Curse
32246819 2020. Pulmonary High-Resolution Computed Tomography (HRCT) Findings of Patients with Early-Stage Coronavirus Disease 2019 (COVID-19) in Hangzhou, China






32333644 2020. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2
32183357 2020. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics
32106462 2020. Disposable DNA Amplification Chips with Integrated Low-Cost Heaters ?




32367213 ä. CT-Verlauf einer Coronavirus(2019-nCoV)-Pneumonie
32358406 2020. COVID-19 with cystic features on computed tomography: A case report



32344326 2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries



32336080 2020. Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience
32236089 2020. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR)
32268719 2020. Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?



32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32271125 2020. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
32220612 2020. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
32220611 2020. Commentary: COVID-19 in patients with diabetes
32275971 ä. COVID-19 in patients with diabetes: risk factors that increase morbidity
32360211 ä. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32360397 ä. Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy
32353356 ä. Obesity: the ?Achilles heel? for COVID-19?
32333939 2020. Importance of metabolic health in the era of COVID-19
32333938 2020. Obesity hypoventilation syndrome and severe COVID-19
32320741 2020. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32320742 ä. COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next?
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection



32219356 ä. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
32369030 2020. Considerations for Postacute Rehabilitation for Survivors of COVID-19
32333842 2020. The key role of palliative care in response to the COVID-19 tsunami of suffering
32197096 ä. COVID-19 in pregnant women ? Authors reply



32224310 ä. Clinical and virological data of the first cases of COVID-19 in Europe: a case series
32164830 2020. COVID-19 with spontaneous pneumomediastinum
32229159 ä. SARS-CoV-2 infection presenting with hematochezia



32220650 ä. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
32087116 2020. Asymptomatic cases in a family cluster with SARS-CoV-2 infection
32105632 ä. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
32379729 2020. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020
32214079 2020. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
32290644 2020. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India


32305438 ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19
32309814 ä. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries




32290293 2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials
32363333 ä. A real-time dashboard of clinical trials for COVID-19


C7158785 ä. Convalescent plasma: A possible treatment of COVID-19 in India
32217166 2020. Chloroquine and COVID-19, where do we stand??
32240719 ä. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
32353355 ä. Testosterone, a key hormone in the context of COVID-19 pandemic
32344177 2020. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
32305500 ä. Chloroquine paradox may cause more damage than help fight COVID-19
32370766 2020. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
32307014 2020. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
32255312 2020. A possible probiotic (S salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SARS-CoV-2
32365556 2020. Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-gamma as Candidates for Cytokine Storm Modulation in COVID-19 Disease
32316270 2020. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
32231349 2020. Chloroquine in COVID-19: the evidence
32231348 2020. Emerging prophylaxis strategies against COVID-19




32303482 ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case
32299784 ä. How do we decide to de-isolate COVID-19 patients?
32105304 2020. Positive RT-PCR Test Results in Patients Recovered From COVID-19



32276848 ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
32224116 ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?
32035510 2020. 2019-nCoV transmission through the ocular surface must not be ignored
32199469 2020. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples



32340347 2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough
32360356 ä. Putting some context to the aerosolization debate around SARS-CoV-2



32129805 2020. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
32203710 2020. Rational use of face masks in the COVID-19 pandemic
32344688 2020. 3-D Printed Protective Equipment during COVID-19 Pandemic



32322988 ä. Umgang mit COVID-19 in der Notaufnahme: Erfahrungsbericht der interdisziplinären Notaufnahme des Universitätsklinikums Münster
32329322 2020. In considerations of robotic colorectal surgery within a COVID-19 pandemic
32327626 2020. Management of inflammatory bowel disease during COVID-19 pandemic
32225135 2020. Pathways for urology patients during the COVID-19 pandemic
32202401 2020. Urology practice during COVID-19 pandemic
32253371 2020. Impact of the COVID-19 pandemic on urology residency training in Italy
32368875 2020. Guide for Nuclear Medicine Applications During the COVID-19 Outbreak
32210421 2020. COVID-19 in intensive care Some necessary steps for health care workers
32297490 2020. COVID-19 pandemic: what consequences for cardiac rehabilitation?




32035030 2020. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus
32085839 2020. Mental health care for medical staff in China during the COVID-19 outbreak
32291383 2020. Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID-19) in Hubei, China


32294078 2020. Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020



32283124 ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic



32305069 ä. Protecting workers aged 60?69 years from COVID-19
32219471 ä. Mutterschutz ? auch im Zeitalter der Coronakrise







32236594 2020. Possibility of transmission through dogs being a contributing factor to the extreme Covid-19 outbreak in North Italy



32282789 2020. Public Health Interventions to Mitigate Early Spread of SARS-CoV-2 in Poland
32244041 2020. Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
32088333 2020. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases
32087334 2020. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future
32278074 ä. Emergency response to the outbreak of COVID-19: the Korean case
32379733 2020. Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24-April 21, 2020
32379731 2020. COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020
32352957 2020. Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U S Cities, March 27-April 15, 2020
32134909 2020. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020
32324720 2020. Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 ? National Poison Data System, United States, January 1, 2020?March 31, 2020
32298247 2020. Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020








32334040 ä. The fate of house cats during the COVID-19 pandemic





32203708 ä. COVID-19 outbreak: less stethoscope, more ultrasound
32192583 2020. COVID-19: delay, mitigate, and communicate
32344311 2020. 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruc?al?ty of Fur?n and relevance w?th cancer
32360951 2020. The first Ramadan during COVID-19 pandemic: 1 8 billion Muslims should fast or not?
32368884 2020. Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain



C7118609 ä. NetNCSP: Nonoverlapping closed sequential pattern mining
32365567 2020. Lab-on-a-Chip Technologies for the Single Cell Level: Separation, Analysis, and Diagnostics


  • from the ads
  • [lifechemicals.com antiviral candidate drugs]
  • [biomol.com assays cytokines general spectrum]
  • [labospace.com custom single probe assay 400 possible cytokines and so on]
  • [codexdna.com dna synthesis]
  • [eclipsebio.com around rna]
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis